Cronos Group Inc. (CRON) Form 8-K — Oct 15, 2026
$CRONForm 8-KItems 1.01, 2.01, 7.01, 9.01Filed Oct 15, 2026, 7:02 AM ET0001656472-26-000061Original filing
Cronos Group completed its acquisition of CanAdelaar B.V. on October 15, 2026, acquiring Europe's largest adult-use cannabis company for a base purchase price of €57.5 million plus cash earnouts equal to 0.5x CanAdelaar's Normalized EBITDA for each of 2026 and 2027. CanAdelaar is the market leader in the Netherlands' Wietexperiment, operating a 540,000-square-foot greenhouse with roughly 20,000 kg of annual dried flower yield and €41.6 million in annualized 1H 2026 net revenue. Cronos' subsidiary CGM B.V.
Key figures
- Deal Value Usd
- €57.5 million base purchase price (plus cash earnout of 0.5x CanAdelaar Normalized EBITDA for each of 2026 and 2027)
- Dcmr proposed penalty
- €12,500,000
- Edibles indemnity cap
- €100,000
- Greenhouse facility sqft
- 540000
- Acquisition multiple ebitda
- 2.9x Adjusted EBITDA
- Annual cultivation yield kg
- 20000
- Canadelaar net revenue 2024
- €15.2 million
- Acquisition multiple revenue
- 1.4x net revenue
- Landewyck facility settlement
- €5,000,000
- Indemnity cap first two matters
- €22,500,000
- Canadelaar net revenue ttm sep2025
- €40.6 million
- Canadelaar net revenue annualized 1h2026
- €41.6 million
- Canadelaar adjusted ebitda annualized 1h2026
- €20.1 million
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.